CONFLICT OF INTEREST
MP receives research funding from various organisations including the
Governmental bodies such as the MRC, EU Commission and Health Education
England. MP also received partnership funding for the following: MRC
Clinical Pharmacology Training Scheme (co-funded by MRC and Roche, UCB,
Eli Lilly and Novartis); a PhD studentship jointly funded by EPSRC and
Astra Zeneca; and grant funding from Vistagen Therapeutics. MP also
received unrestricted educational grant support for the UK
Pharmacogenetics and Stratified Medicine Network from Bristol-Myers
Squibb and UCB. MP held a joint grant from NIHR with MC Diagnostics for
the development of a HLA panel. None of the funding MP received is
related to the current paper.
The remaining authors declare no conflicts of interest.